Sage Therapeutics (SAGE, $13.27) was a top loser over the last three months, falling -4 to $13.27 per share. A.I.dvisor analyzed 915 stocks in the Biotechnology Industry for the 3-month period ending May 1, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.